Along with others, Zinovkin and Grebenchikov are now conducting clinical trials to test Nrf2 inducers for preventing and treating the cytokine storm associated with severe cases of COVID-19 disease.

The authors suggest that the cytokine storm and lymphopaenia observed in ... These results provide some interesting insights into the mechanisms of action of CD28 superagonisitc antibodies ...